Skip to content
PubMed This is a summary of 12 peer-reviewed journal articles Updated
Pediatric Neurology

Standard of Care and Multidisciplinary Management

At a Glance

The standard of care for cobblestone lissencephaly relies on a multidisciplinary team to proactively manage symptoms and improve the child's quality of life. Key interventions include feeding support to prevent aspiration, neurological care for seizures and hydrocephalus, and physical therapy.

While there is currently no cure for cobblestone lissencephaly, the standard of care has become highly proactive and supportive. The goal of modern management is not just to treat symptoms as they arise, but to anticipate your child’s needs and provide a “safety net” that improves their comfort, function, and overall quality of life.

The Care Team Roster

Because alpha-dystroglycanopathies can affect the brain, muscles, eyes, and heart, your child will need a “team of experts” working together. This multidisciplinary approach is the gold standard of care [1]. Your team will likely include:

  • Pediatric Neurologist: The lead for managing brain development, movement, and epilepsy (seizures) [2].
  • Neurosurgeon: Monitors and treats hydrocephalus (fluid buildup) [3].
  • Gastroenterologist (GI) & Nutritionist: Essential for managing severe reflux, constipation, and ensuring safe feeding [1].
  • Pulmonologist (Lung Specialist): Monitors the strength of the muscles used for breathing and clearing the airway [4].
  • Orthopedist: Monitors bone growth, spine curvature, and joint health [1].
  • Cardiologist (Heart Specialist): Performs regular checks (echocardiograms) to ensure the heart muscle remains strong [5].
  • Palliative / Complex Care Team: Specialists focused entirely on managing difficult symptoms and maximizing the child’s quality of life [1].

Feeding, Swallowing, and GI Health

One of the most critical daily challenges is safely feeding your child. Due to severe low muscle tone (hypotonia), swallowing can be difficult and uncoordinated.

  • Aspiration Risk: Uncoordinated swallowing creates a high risk of aspiration (food or liquid going into the lungs instead of the stomach), which can lead to severe, life-threatening respiratory infections [1].
  • Feeding Tubes: Because of this risk, many children benefit greatly from a feeding tube (such as a G-tube). A feeding tube ensures they receive safe, adequate nutrition and hydration without the stress, fatigue, or danger of choking [1].

Bone and Joint Health

Children with severe muscle weakness are at high risk for developing orthopedic complications as they grow:

  • Contractures and Scoliosis: Without the constant pull of strong muscles, joints can become stiff and locked into place (contractures), and the spine can begin to curve (scoliosis) [1].
  • Management: Physical therapy, specialized bracing (like AFOs for the legs or soft spinal braces), and regular orthopedic monitoring are critical to keeping your child comfortable and properly positioned [1].

Managing Brain and Nerve Health

The two most common neurological concerns are brain pressure and seizures.

  • Hydrocephalus: If fluid builds up in the brain, a neurosurgeon may place a VP shunt—a small, internal tube that drains excess fluid to another part of the body where it can be safely absorbed [3][6].
  • Epilepsy: Seizures are very common due to the way neurons are organized [7]. Doctors use a variety of medications tailored to your child’s specific seizure type. If medications aren’t enough, specialized diets like the ketogenic or modified Atkins diet may be considered [8].

The Role of Palliative Care

It is important to understand that palliative care is not the same as hospice. A palliative or complex care team provides an extra layer of support focused entirely on symptom management (like pain, irritability, or severe reflux) and quality of life. They are a vital resource to help you navigate complex medical decisions and ensure your child is as comfortable as possible from the day of diagnosis [1].

Emerging Research

We are entering a new era of “genetic medicine” where scientists are working on treatments that target the root cause of these conditions:

  • Ribitol Supplementation: For children with mutations in the FKRP gene, researchers are studying a specialized sugar called ribitol (or BBP-418). Note: Current clinical trials for ribitol are primarily focused on patients with Limb-Girdle Muscular Dystrophy (LGMD2I/R9) — a milder, muscle-only form of the disease — rather than the severe brain malformations seen in cobblestone lissencephaly [9]. However, this research proves the pathway can be targeted.
  • Gene Therapy: Scientists are using “delivery vehicles” called AAV vectors to carry healthy copies of genes directly into the cells [10][11]. While mostly in the preclinical or early trial stages, this research aims to restore functional glycosylation and improve muscle strength [11][12].

Your child’s care is a marathon, not a sprint. By building a strong team, prioritizing safety in feeding and breathing, and leaning on support specialists, you are providing your child with the best possible foundation for the journey ahead.

Common questions in this guide

Who should be on my child's medical care team for cobblestone lissencephaly?
Because the condition affects multiple body systems, your child will need a coordinated care team. This typically includes a pediatric neurologist, neurosurgeon, gastroenterologist, pulmonologist, orthopedist, cardiologist, and a palliative care team.
How can I make sure my child is feeding safely?
Severe low muscle tone can make swallowing difficult, creating a high risk for aspiration where food enters the lungs. A swallow study can check for safety, and many children benefit from a feeding tube to receive adequate nutrition without choking risks.
What are the common neurological treatments for this condition?
The two most common neurological concerns are brain fluid buildup and seizures. Treatments may include a neurosurgeon placing a VP shunt to drain excess fluid, and using targeted medications or specialized diets to manage epilepsy.
What is the role of palliative care for cobblestone lissencephaly?
Palliative care provides an extra layer of support focused entirely on symptom management and quality of life. It is not the same as hospice, and is a vital resource to help you navigate complex medical decisions from the day of diagnosis.
Are there any targeted treatments or cures available for cobblestone lissencephaly?
There is currently no cure, but emerging research is exploring targeted therapies like gene therapy and specialized sugar supplements. These are primarily in early clinical trials or focused on milder forms of muscular dystrophy, but they offer hope for the future.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Who is the 'coordinator' of my child's multidisciplinary team? Whom should I contact first when new symptoms appear?
  2. 2.Has a swallow study been ordered to ensure my child is eating safely without aspirating?
  3. 3.What specific respiratory and cardiac screenings do we need, and how often should they be repeated as my child grows?
  4. 4.Can you connect us with a palliative or complex care team to help us manage daily symptoms and improve our child's quality of life?
  5. 5.How can we adapt physical therapy to support my child's development while protecting their fragile muscles and joints?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (12)
  1. 1

    283rd ENMC international workshop: Establishing expert care recommendations for LAMA2-RD: A prototype for the development of congenital muscular dystrophy subtype-specific care guidelines. Hoofddorp, The Netherlands, January 17th-19th 2025.

    Zambon AA, Klein A, Sarkozy A, et al.

    Neuromuscular disorders : NMD 2025; (55()):106220 doi:10.1016/j.nmd.2025.106220.

    PMID: 41106238
  2. 2

    Characteristic Cochlear Hypoplasia in Patients with Walker-Warburg Syndrome: A Radiologic Study of the Inner Ear in α-Dystroglycan-Related Muscular Disorders.

    Talenti G, Robson C, Severino MS, et al.

    AJNR. American journal of neuroradiology 2021; (42(1)):167-172 doi:10.3174/ajnr.A6858.

    PMID: 33122211
  3. 3

    A Successful Treatment of Endoscopic Third Ventriculostomy with Choroid Plexus Cauterization for Hydrocephalus in Walker-Warburg Syndrome.

    Tanaka T, Harris CJ, Barnett SS, Litofsky NS

    Case reports in neurological medicine 2016; (2016()):7627289 doi:10.1155/2016/7627289.

    PMID: 28116189
  4. 4

    Dropped head congenital muscular dystrophy caused by de novo mutations in LMNA.

    Karaoglu P, Quizon N, Pergande M, et al.

    Brain & development 2017; (39(4)):361-364 doi:10.1016/j.braindev.2016.11.002.

    PMID: 27876398
  5. 5

    Congenital LMNA-Related Muscular Dystrophy in Paediatrics: Cardiac Management in Monozygotic Twins.

    Martínez Olorón P, Alegría I, Cesar S, et al.

    International journal of molecular sciences 2024; (25(11)) doi:10.3390/ijms25115836.

    PMID: 38892025
  6. 6

    Bilateral total retinal detachment at birth: a case report of Walker-Warburg syndrome.

    Hakim N, Soare C, Hakim J

    International medical case reports journal 2018; (11()):1-4 doi:10.2147/IMCRJ.S154223.

    PMID: 29386918
  7. 7

    Seizures and EEG characteristics in a cohort of pediatric patients with dystroglycanopathies.

    Yang H, Song D, Liu Y, et al.

    Seizure 2022; (101()):39-47 doi:10.1016/j.seizure.2022.07.008.

    PMID: 35863218
  8. 8

    Qualitative exploration of feasibility and acceptability of the modified Atkins diet therapy for children with drug resistant epilepsy in Kenya.

    Samia P, Naanyu V, Cross JH, et al.

    Epilepsy & behavior : E&B 2021; (125()):108362 doi:10.1016/j.yebeh.2021.108362.

    PMID: 34740092
  9. 9

    CDP-ribitol prodrug treatment ameliorates ISPD-deficient muscular dystrophy mouse model.

    Tokuoka H, Imae R, Nakashima H, et al.

    Nature communications 2022; (13(1)):1847 doi:10.1038/s41467-022-29473-4.

    PMID: 35422047
  10. 10

    Advancements in Dravet Syndrome Therapeutics: A Comprehensive Look at Present and Future Treatment Horizons: A Focused Review.

    Mahesan A, Kamila G, Gulati S

    Annals of Indian Academy of Neurology 2024; (27(4)):352-357 doi:10.4103/aian.aian_49_24.

    PMID: 39196806
  11. 11

    Dual FKRP/FST gene therapy normalizes ambulation, increases strength, decreases pathology, and amplifies gene expression in LGMDR9 mice.

    Lam P, Zygmunt DA, Ashbrook A, et al.

    Molecular therapy : the journal of the American Society of Gene Therapy 2024; (32(8)):2604-2623 doi:10.1016/j.ymthe.2024.06.028.

    PMID: 38910327
  12. 12

    Efficacy of Gene Therapy Is Dependent on Disease Progression in Dystrophic Mice with Mutations in the FKRP Gene.

    Vannoy CH, Xiao W, Lu P, et al.

    Molecular therapy. Methods & clinical development 2017; (5()):31-42 doi:10.1016/j.omtm.2017.02.002.

    PMID: 28480302

This page is for informational purposes only and does not replace professional medical advice. Always consult your child's healthcare team for specific treatment and multidisciplinary management decisions.

Get notified when new evidence is published on Cobblestone lissencephaly.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.